MORPHOSYS AG O.N. - Daily - Technical analysis published on 05/02/2023 (GMT)
- 131
- 0
Oops, I was wrong about that analysis. My threshold for invalidation has been broken.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : INVALID
MORPHOSYS AG O.N. Chart
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
67%
0%
33%
My opinion
Bullish above 19.325 EUR
My targets
20.890 EUR (+6.23%)
22.230 EUR (+13.04%)
My analysis
The bullish trend is currently very strong on MORPHOSYS AG O.N.. As long as the price remains above the support at 19.325 EUR, you could try to benefit from the boom. The first bullish objective is located at 20.890 EUR. The bullish momentum would be boosted by a break in this resistance. Buyers would then use the next resistance located at 22.230 EUR as an objective. Crossing it would then enable buyers to target 23.350 EUR. Be careful, given the powerful bullish rally underway, excesses could lead to a possible correction in the short term. If this is the case, remember that trading against the trend may be riskier. It would seem more appropriate to wait for a signal indicating reversal of the trend.
Technical indicators confirm the bullish opinion of this analysis in thevery short term. However, be careful of excessive bullish movements. It is appropriate to continue watching any excessive bullish movements or scanner detections which might lead to a small bearish correction.
Force
0
10
8.2
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Londinia.
Additional analysis
Quotes
MORPHOSYS AG O.N. rating 19.665 EUR. On the day, this instrument gained +3.17% with the lowest point at 19.180 EUR and the highest point at 19.960 EUR. The deviation from the price is +2.53% for the low point and -1.48% for the high point.19.180
19.960
19.665
A bullish gap was detected at the opening by the Central Gaps scanner. There are a lot of buyers and they have the upper hand in the very short term.
Opening Gap UP
Type : Bullish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Near a new HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
A technical analysis in Daily of this MORPHOSYS AG O.N. chart shows a strongly bullish trend. 92.86% of the signals given by moving averages are bullish. This strongly bullish trend is supported by the strong bullish signals given by short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
The technical indicators are bullish. There is still some doubt about the price increase.
Caution: the Central Indicators scanner currently detects an excess:
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : Daily
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found this result:
Horizontal resistance is broken
Type : Bullish
Timeframe : Daily
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 13.635 | 16.518 | 19.325 | 19.665 | 20.890 | 22.230 | 23.350 |
Change (%) | -30.66% | -16.00% | -1.73% | - | +6.23% | +13.04% | +18.74% |
Change | -6.030 | -3.147 | -0.340 | - | +1.225 | +2.565 | +3.685 |
Level | Minor | Major | Major | - | Minor | Minor | Intermediate |
Attention could also be paid to pivot points to set price objectives:
Daily
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 17.872 | 18.183 | 18.622 | 18.933 | 19.372 | 19.683 | 20.122 |
Camarilla | 18.854 | 18.923 | 18.991 | 19.060 | 19.129 | 19.198 | 19.266 |
Woodie | 17.935 | 18.215 | 18.685 | 18.965 | 19.435 | 19.715 | 20.185 |
Fibonacci | 18.183 | 18.470 | 18.647 | 18.933 | 19.220 | 19.397 | 19.683 |
Weekly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 16.837 | 17.653 | 18.357 | 19.173 | 19.877 | 20.693 | 21.397 |
Camarilla | 18.642 | 18.781 | 18.921 | 19.060 | 19.199 | 19.339 | 19.478 |
Woodie | 16.780 | 17.625 | 18.300 | 19.145 | 19.820 | 20.665 | 21.340 |
Fibonacci | 17.653 | 18.234 | 18.593 | 19.173 | 19.754 | 20.113 | 20.693 |
Monthly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 9.220 | 11.560 | 15.310 | 17.650 | 21.400 | 23.740 | 27.490 |
Camarilla | 17.385 | 17.944 | 18.502 | 19.060 | 19.618 | 20.177 | 20.735 |
Woodie | 9.925 | 11.913 | 16.015 | 18.003 | 22.105 | 24.093 | 28.195 |
Fibonacci | 11.560 | 13.886 | 15.324 | 17.650 | 19.976 | 21.414 | 23.740 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
Technical indicators
Moving averages
RSI (14): | 68.74 | |
MACD (12,26,9): | 0.9370 | |
Directional Movement: | 19.714 | |
AROON (14): | 64.286 | |
DEMA (21): | 19.327 | |
Parabolic SAR (0,02-0,02-0,2): | 18.495 | |
Elder Ray (13): | 0.884 | |
Super Trend (3,10): | 17.099 | |
Zig ZAG (10): | 19.665 | |
VORTEX (21): | 1.2060 | |
Stochastique (14,3,5): | 77.78 | |
TEMA (21): | 19.963 | |
Williams %R (14): | -11.75 | |
Chande Momentum Oscillator (20): | 0.955 | |
Repulse (5,40,3): | 4.5420 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.7910 | |
Courbe Coppock: | 32.63 |
MA7: | 19.207 | |
MA20: | 17.996 | |
MA50: | 16.597 | |
MA100: | 16.293 | |
MAexp7: | 19.136 | |
MAexp20: | 18.169 | |
MAexp50: | 17.196 | |
MAexp100: | 17.036 | |
Price / MA7: | +2.38% | |
Price / MA20: | +9.27% | |
Price / MA50: | +18.49% | |
Price / MA100: | +20.70% | |
Price / MAexp7: | +2.76% | |
Price / MAexp20: | +8.23% | |
Price / MAexp50: | +14.36% | |
Price / MAexp100: | +15.43% |
Quotes :
-
15 min delayed data
-
Germany Stocks
News
The last news published on MORPHOSYS AG O.N. at the time of the generation of this analysis was as follows:
- EQS-News: Invitation to MorphoSys’ First Quarter 2023 Financial Results Conference Call on May 4, 2023
- Invitation to MorphoSys’ First Quarter 2023 Financial Results Conference Call on May 4, 2023
- EQS-News: MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix)
- EQS-News: MorphoSys Completes Enrollment of Phase 3 MANIFEST-2 Study of Pelabresib in Myelofibrosis with Topline Results Expected by End of 2023
- EQS-News: MorphoSys AG: Repurchase of portion of outstanding convertible bonds due 2025 (ISIN DE000A3H2XW6)
This member declared not having a position on this financial instrument or a related financial instrument.
About author
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis MORPHOSYS AG O.N. - Daily